dogn, This is fantastic information. I take it from this that KM has completed his work in Europe. Now he is turning his focus to the US market. I saw some wording about pharmacutical transportation. If KM has a way to cut out the pharmacy and supply the drug directly to patients, that would squeeze the generics. Sleven,
dogn, could this info be the reason why amarin has been low keyed recently? It appears they're going for a total remake of marketing strategy. No recent tweets, maybe they've been intentionally going off the grid to introduce the New Amarin. YEAH!
News 
Market Data 
Discover 
